Anita Kamra Verma

Atrial Overdrive Pacing for the Obstructive Sleep Apnea-Hypopnea SyndromeSimantirakis EN, Schiza SE, Chrysostomakis SI, et al (Heraklion Univ Hosp, Greece) N Engl J Med 353:2568–2577, 2005§

Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease

Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patientsVenkataramana A, Pardo CA, McArthur JC, et al (Johns Hopkins Univ, Baltimore, Md) Neurology 67:383–388, 2006§

Randomized Controlled Trial of Intraputamenal Glial Cell Line–Derived Neurotrophic Factor Infusion in Parkinson DiseaseLang AE, Gill S, Patel NK, et al (Univ of Toronto; Frenchay Hosp, Bristol, England; Toronto Western Research Inst; et al) Ann Neurol 59:459–466, 2006§

Natalizumab plus Interferon Beta-1a for Relapsing Multiple SclerosisRudick RA, for the SENTINEL Investigators (Cleveland Clinic Found, Ohio; MS Ctr of Atlanta, Ga; Johns Hopkins Multiple Sclerosis Ctr, Baltimore, Md; et al) N Engl J Med 354:911–923, 2006§

Clinical features associated with impulse control disorders in Parkinson diseasePontone G, Williams JR, Bassett SS, et al (Johns Hopkins Univ, Baltimore, Md) Neurology 67:1258–1261, 2006§

Clinical Spectrum of Homozygous and Heterozygous PINK1 Mutations in a Large German Family With Parkinson Disease: Role of a Single Hit?Hedrich K, Hagenah J, Djarmati A, et al (Univ of Lübeck, Germany; Med Univ of Cologne, Germany; Georg-August Univ, Göttingen, Germany; et al) Arch Neurol 63:833–838, 2006§

Peripheral neuropathy in patients with inflammatory bowel diseaseGondim FAA, Brannagan TH III, Sander HW, et al (Weill Med College of Cornell Univ, New York; Universidade Federal do Ceará, Fortaleza, Brazil) Brain 128:867–879, 2005§

Insular Involvement in Brain Infarction Increases Risk for Cardiac Arrhythmia and DeathAbboud H, Berroir S, Labreuche J, et al (Denis Diderot Univ, Paris; Annemasse Hosp, France) Ann Neurol 59:691–699, 2006§

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple SclerosisPolman CH, for the AFFIRM Investigators (Vrije Universiteit, Amsterdam; St Michael's Hosp, Toronto; Gen Teaching Hosp, Prague, Czech Republic; et al) N Engl J Med 354:899–910, 2006§